Objectives: To identify the main causes of morbidity and mortality in patients with
antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and …

Objectives To assess the prevalence of the main causes of morbi-mortality in the
antiphospholipid syndrome (APS) during a 10-year-follow-up period and to compare the …

OBJECTIVES:: To study the clinical characteristics at diagnosis and during follow-upof
patients with the antiphospholipid syndrome (APS) and to analyze the influence of treatment …

Objective. To assess the longterm frequency of thrombotic recurrences, obstetrical
complications, organ damage, severe comorbidities, and evolution toward connective tissue …

Objectives Although the medical literature currently provides a growing number of isolated
case reports of patients with clinically well-defined antiphospholipid syndrome (APS) and …

Objective. Antiphospholipid antibodies (aPL) are major risk factors for thrombosis. Other
clinical factors exist in antiphospholipid syndrome (APS) patients which may have an …

For patients with antiphospholipid syndrome (APS), the consensus is to treat those who
develop thrombosis with long-term oral anticoagulation therapy and to prevent obstetric …

Objective. To identify the risk factors associated with pregnancy failure in patients with APS
treated with conventional therapy. Methods. A multicentre, case–control study was …

Methods Sixty pregnancies in 47 APS patients (11 primary and 36 secondary) were followed
in a multidisciplinary clinic. Patients testing antiphospholipid antibody positive and having a …

OBJECTIVE: To describe a French tertiary referral center experience in the treatment of
pregnancies in patients with the antiphospholipid syndrome (APS). METHODS …